NO20061951L - Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav - Google Patents
Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater deravInfo
- Publication number
- NO20061951L NO20061951L NO20061951A NO20061951A NO20061951L NO 20061951 L NO20061951 L NO 20061951L NO 20061951 A NO20061951 A NO 20061951A NO 20061951 A NO20061951 A NO 20061951A NO 20061951 L NO20061951 L NO 20061951L
- Authority
- NO
- Norway
- Prior art keywords
- benzoxazole
- preparation
- sulfonamide compounds
- intermediates
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03103630 | 2003-09-30 | ||
| US50799603P | 2003-10-02 | 2003-10-02 | |
| PCT/EP2004/052382 WO2005030739A1 (en) | 2003-09-30 | 2004-09-30 | Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061951L true NO20061951L (no) | 2006-05-02 |
Family
ID=34395298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061951A NO20061951L (no) | 2003-09-30 | 2006-05-02 | Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070123574A1 (da) |
| EP (1) | EP1670773B1 (da) |
| JP (1) | JP4919802B2 (da) |
| KR (1) | KR101090102B1 (da) |
| CN (1) | CN1860107B (da) |
| AP (1) | AP1985A (da) |
| AT (1) | ATE353323T1 (da) |
| AU (1) | AU2004276017B2 (da) |
| BR (1) | BRPI0414916A (da) |
| CA (1) | CA2537877C (da) |
| DE (1) | DE602004004674T2 (da) |
| DK (1) | DK1670773T3 (da) |
| EA (1) | EA011891B1 (da) |
| ES (1) | ES2281828T3 (da) |
| IL (1) | IL173891A0 (da) |
| IN (1) | IN2012DN02301A (da) |
| MX (1) | MXPA06003575A (da) |
| NO (1) | NO20061951L (da) |
| NZ (1) | NZ546279A (da) |
| PL (1) | PL1670773T3 (da) |
| PT (1) | PT1670773E (da) |
| SI (1) | SI1670773T1 (da) |
| WO (1) | WO2005030739A1 (da) |
| ZA (1) | ZA200602603B (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR053845A1 (es) * | 2005-04-15 | 2007-05-23 | Tibotec Pharm Ltd | 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450 |
| US8575186B2 (en) | 2009-10-05 | 2013-11-05 | Albany Molecular Research, Inc. | Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof |
| CA2823955A1 (en) | 2011-01-19 | 2012-07-26 | Albany Molecular Research, Inc. | Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia |
| WO2014194519A1 (en) | 2013-06-07 | 2014-12-11 | Merck Sharp & Dohme Corp. | Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968942A (en) * | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| PT815124E (pt) * | 1995-03-10 | 2003-04-30 | Searle & Co | Inibidores protease retroviral sulfonamida hidroxietilamino aminoacido heterociclocarbonilo |
| EP0861249A1 (en) * | 1995-11-15 | 1998-09-02 | G.D. Searle & Co. | Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| CN1366524A (zh) * | 2000-04-07 | 2002-08-28 | 三星电子株式会社 | 磺胺衍生物作为基质金属蛋白酶抑制剂 |
| US6455738B1 (en) * | 2000-07-13 | 2002-09-24 | Rhodia Chimie | Process for the sulfonation of an aromatic compound |
| SI1370543T1 (sl) * | 2001-02-14 | 2007-04-30 | Tibotec Pharm Ltd | Sirokospektralni 2-(substituirani-amino)-benzotiazol sulfonamidni inhibitorji HIV proteaze |
| CZ304524B6 (cs) * | 2001-05-11 | 2014-06-18 | Tibotec Pharmaceuticals Ltd. | Derivát 2-aminobenzoxazolsulfonamidu, farmaceutická kompozice s jeho obsahem a léčivo pro léčení infekce retroviry |
| TWI286476B (en) * | 2001-12-12 | 2007-09-11 | Tibotec Pharm Ltd | Combination of cytochrome P450 dependent protease inhibitors |
| MY142238A (en) * | 2002-03-12 | 2010-11-15 | Tibotec Pharm Ltd | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
-
2004
- 2004-09-30 PL PL04766869T patent/PL1670773T3/pl unknown
- 2004-09-30 AP AP2006003603A patent/AP1985A/xx active
- 2004-09-30 CA CA2537877A patent/CA2537877C/en not_active Expired - Fee Related
- 2004-09-30 US US10/574,157 patent/US20070123574A1/en not_active Abandoned
- 2004-09-30 KR KR1020067005992A patent/KR101090102B1/ko not_active IP Right Cessation
- 2004-09-30 MX MXPA06003575A patent/MXPA06003575A/es active IP Right Grant
- 2004-09-30 BR BRPI0414916-5A patent/BRPI0414916A/pt not_active IP Right Cessation
- 2004-09-30 AU AU2004276017A patent/AU2004276017B2/en not_active Ceased
- 2004-09-30 EA EA200600699A patent/EA011891B1/ru not_active IP Right Cessation
- 2004-09-30 NZ NZ546279A patent/NZ546279A/en not_active IP Right Cessation
- 2004-09-30 ES ES04766869T patent/ES2281828T3/es not_active Expired - Lifetime
- 2004-09-30 DK DK04766869T patent/DK1670773T3/da active
- 2004-09-30 AT AT04766869T patent/ATE353323T1/de active
- 2004-09-30 IN IN2301DEN2012 patent/IN2012DN02301A/en unknown
- 2004-09-30 EP EP04766869A patent/EP1670773B1/en not_active Expired - Lifetime
- 2004-09-30 CN CN2004800280971A patent/CN1860107B/zh not_active Expired - Fee Related
- 2004-09-30 DE DE602004004674T patent/DE602004004674T2/de not_active Expired - Lifetime
- 2004-09-30 SI SI200430265T patent/SI1670773T1/sl unknown
- 2004-09-30 JP JP2006530265A patent/JP4919802B2/ja not_active Expired - Fee Related
- 2004-09-30 PT PT04766869T patent/PT1670773E/pt unknown
- 2004-09-30 WO PCT/EP2004/052382 patent/WO2005030739A1/en active IP Right Grant
-
2006
- 2006-02-22 IL IL173891A patent/IL173891A0/en not_active IP Right Cessation
- 2006-03-29 ZA ZA200602603A patent/ZA200602603B/xx unknown
- 2006-05-02 NO NO20061951A patent/NO20061951L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR101090102B1 (ko) | 2011-12-07 |
| WO2005030739A1 (en) | 2005-04-07 |
| DE602004004674T2 (de) | 2007-11-22 |
| CN1860107A (zh) | 2006-11-08 |
| KR20060092224A (ko) | 2006-08-22 |
| IL173891A0 (en) | 2006-07-05 |
| CN1860107B (zh) | 2013-08-21 |
| IN2012DN02301A (da) | 2015-08-14 |
| AU2004276017B2 (en) | 2010-08-19 |
| DK1670773T3 (da) | 2007-05-29 |
| PT1670773E (pt) | 2007-05-31 |
| EP1670773B1 (en) | 2007-02-07 |
| CA2537877C (en) | 2015-03-17 |
| SI1670773T1 (sl) | 2007-06-30 |
| AP1985A (en) | 2009-03-30 |
| ZA200602603B (en) | 2008-05-28 |
| ES2281828T3 (es) | 2007-10-01 |
| JP2007507468A (ja) | 2007-03-29 |
| EA011891B1 (ru) | 2009-06-30 |
| JP4919802B2 (ja) | 2012-04-18 |
| BRPI0414916A (pt) | 2006-11-07 |
| MXPA06003575A (es) | 2006-06-05 |
| CA2537877A1 (en) | 2005-04-07 |
| US20070123574A1 (en) | 2007-05-31 |
| DE602004004674D1 (de) | 2007-03-22 |
| ATE353323T1 (de) | 2007-02-15 |
| PL1670773T3 (pl) | 2007-06-29 |
| EP1670773A1 (en) | 2006-06-21 |
| EA200600699A1 (ru) | 2006-08-25 |
| AP2006003603A0 (en) | 2006-04-30 |
| NZ546279A (en) | 2008-09-26 |
| AU2004276017A1 (en) | 2005-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20050199L (no) | Azadisyklo-oktan og nonanderivater med DDP-IV-inhiberende aktivitet | |
| NO20014484D0 (no) | Nye forbindelser og sammensetninger som proteaseinhibitorer | |
| DE60312031D1 (de) | Hydroxyethylamin-derivate für die behandlung von alzheimer | |
| NO20012921L (no) | Fenylglycin-derivater | |
| NO20040313L (no) | Nye forbindelser | |
| NI200700056A (es) | Nuevos derivados de sulfamidas de heteroaril benzo-fundido útiles como agentes anticonvulsivos | |
| CY1107817T1 (el) | Καρβοξαμιδια θειοφαινιου ως αναστολεις του ενζυμου ικκ-2 | |
| CY1109379T1 (el) | Διεργασια για την παρασκευη (3r,3αs,6αr)-εξαϋδροφουρο [2,3-β] φουραν-3-υλ (1s,2r)-3-[[(4-αμινοφαινυλ) σουλφονυλ] (ισοβουτυλ) αμινο]-1-βενζυλ-2-υδροξυπροπυλκαρβαμικου | |
| GT200500257AA (es) | Procedimiento para producir derivados de amina opticamente activos | |
| DK1789398T3 (da) | 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE) | |
| SE0403171D0 (sv) | New compounds | |
| HRP20050352A2 (en) | Piperazinyl and diazapanyl benzamides and benzthioamides | |
| NO20005261L (no) | Nye heterocyklisk substituerte amider med cystein-protease- inhiberende virkning | |
| NO20034667L (no) | Arylsulfonamider som antivirale midler | |
| NO20061951L (no) | Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav | |
| NO20060258L (no) | Nematicidale tiazolin-inneholdende fluorobutener | |
| ATE451370T1 (de) | Verbesserte verfahren zur herstellung von n-(ä1,2,4ütriazolopyrimidin-2-yl)arylsulfonamid n | |
| AR039937A1 (es) | Derivados de azetidina como inhibidores de tripsina proteasas | |
| NO20050612L (no) | Pyrrolidinderivater som oksytocinantagonister | |
| NO20044881L (no) | Acyl-3-karboksyfenylureaderivater, fremstillingsfremgangsmate og anvendelse derav | |
| MEP48608A (en) | Piperazine containing phosphonic acid compounds as inhibitors of serine proteases | |
| UY25220A1 (es) | Nuevas formas polimórficas | |
| UA86030C2 (ru) | Способ получения соединений бензоксазолсульфонамида (варианты) и промежуточные соединения | |
| DK1819704T3 (da) | Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase | |
| DK1585728T3 (da) | Iminosyrederivater som inhibitorer af matrix-metalloproteinaser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |